United Health GroupInc., an American multinational healthcare and insurance company headquartered in Minnesota First quarter 2023 earnings result 14y April (Friday)And before open market. The company operates through different segments namely United Health Care (coordinates patient care, improves medical care affordability, analyzes cost trends, manages pharmacy benefits, works with providers more effectively and creates a simpler experience for the consumer), OptumHealth (Provides health and wellness care and serves the broad healthcare market including payers, caregivers, employers, government, life sciences companies, and consumers), insight (Focusing on data, analytics, technology and information) f optumRx (Provides pharmaceutical care services). As of the latest 2022 records, UnitedHealth Group is Rank The second largest healthcare company, which is also the 12th largesty The largest company worldwide based on revenue.
Figure 1 UnitedHealth Group reported sales versus analyst expectations: CNN Business
UnitedHealth Group’s sales were on par with analyst expectations in fiscal 2022, at more than $80 billion per quarter. Total reported sales for the year were $324.2 billion, beating estimates of $323.9 billion. In the next quarter, sales estimates held steady at $89.7 billion, up 8.33% from the previous quarter, and nearly 12% from the same period last year.
Figure 2：UnitedHealth Group’s reported EPS vs Analyst Forecast： CNN Business
Likewise, EPS has beaten consensus estimates in every quarter from last year, between $5.34 – $5.79. In the first quarter of 2023, the number is estimated to reach $6.16Over 15% From the previous quarter onwards 12% From the same period last year.
Essentially, based on historical financial results and forecast estimates, UnitedHealth Group is undoubtedly a financially stable company with positive growth prospects, despite the current unfavorable macro-economic trends hitting companies across sectors and the fact that healthcare stocks are defensive in nature after demand. Inelastic in the healthcare industry. All in all, UnitedHealth is rated by Analysts as “buy”.
Technical Analysis:
The #UnitedHealth (United nationsThe share price traded uniformly in the first quarter of 2023, leaving an all-time high of $557.98. Last week, it rose higher above the February high ($504.10 USD), closes at $512.23. The weekly winnings were over 6%driven b Good news on the public health front. On the daily chart, the company’s share price is still supported above $507.70 USD, or FR 50.0% extended from ATH to session lows seen in February. As long as the support level remains intact, the bulls may continue to test the next resistance at $519.60 (FR 61.8%), followed by $536.50 (FR 78.6%). On the other hand, if the stock price corrects and breaks the mentioned support, the bears may test the 100-day simple moving average dynamic support and $495.85 (FR38.2%), then $481.20 (France 23.6%).
click here To access our economic calendar
Larence Chang
Market analyst
Disclaimer: This material is provided as general marketing communication for informational purposes only and does not constitute independent investment research. Nothing in this communication contains, or should be deemed to contain, investment advice, investment recommendation or solicitation for the purpose of buying or selling any financial instrument. All information provided is collected from reputable sources and any information containing an indication of past performance is not a guarantee or a reliable indicator of future performance. Users acknowledge that any investment in leveraged products is characterized by a certain degree of uncertainty and that any such investment involves a high level of risk for which the Users are solely responsible. We accept no liability for any loss arising from any investment made based on the information contained in this communication. This communication must not be reproduced or distributed again without our prior written permission.
Comments are closed.